All lobbying filings

BAXTER HEALTHCARE CORPORATION

Lobbying for BAXTER HEALTHCARE CORPORATION

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $390,000.00 expenses · posted Jul 16, 2025

Official filing document

Lobbying activity 5

Medicare/Medicaid

Issues related to pharmaceutical pricing. Issues related to drug shortages.

Health Issues

Issues relating to drug pricing, 340B Drug pricing, device sterilization. Issues relating to safe mobility and issues relating to diabetic retinopathy. Issues relating to pandemic preparedness act. Issues related to artificial intelligence technology in healthcare; issues related to Hurricane Helene. Issues around emergency preparedness and critical medical supplies.

Budget/Appropriations

Issues related to increasing funding for Strategic National Stockpile. Labor, Health, and Human Services appropriations.

Taxation/Internal Revenue Code

Taxation of multinational companies. Monitor tax reform proposal relating to corporate tax policies.

Trade (domestic/foreign)

None.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.